I’m a retina specialist who takes care of patients who have problems with the back of the eye. When a patient comes to see me, I like getting to know them and their history, so that I can tailor their treatment. My patients come from a variety of different backgrounds, so I find that I often learn as much from them as they do from me. Everybody has a different story and I very much like to learn about the patients to whom I provide care. Duke is a great place at which to work and from which to seek treatment because it’s a very collaborative institution. Everyone works together to do what’s best for the patient. Outside of work, I like to spend as much time as possible with my family. I also enjoy cooking, playing sports and watching sports. Dr. Jaffe is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Trabeculectomy.

Jay Chhablani is an Ophthalmologist in Pittsburgh, Pennsylvania. Dr. Chhablani is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal. Dr. Chhablani is currently accepting new patients.

Peter Kaiser is an Ophthalmologist in Cleveland, Ohio. Dr. Kaiser has been practicing medicine for over 38 years and is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Vitrectomy, and Osteotomy.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Vision is so intricately related to one's quality of life. Many patients who come to the Duke Eye Center are concerned that they could be going blind, but they rarely ask that question directly. It is important that my patients clearly understand their eye disease process, the risks, benefits and all treatment options so that we can make joint decisions. I try to reassure, when possible, and share the positives, such as 'their eye condition may only affect one eye' or that 'it is possible to improve their vision or prevent further visual loss'. We also discuss how other health problems or lifestyle decisions can affect their visual health. When someone has a vision threatening condition, it is my goal to ensure that they know that, as their physician, I will advise them and guide them through their treatment and the often complicated medical system. I enjoy what I do every day as part of the Duke Health family!. Dr. Fekrat is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. Her top areas of expertise are Retinal Vein Occlusion, Mesenteric Venous Thrombosis, Endophthalmitis, Vitrectomy, and Cataract Removal.

Ehsan Rahimy is an Ophthalmologist in San Carlos, California. Dr. Rahimy has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy. Dr. Rahimy is currently accepting new patients.

Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

I am a Duke vitreoretinal surgeon and Moorfields uveitis trained ophthalmologist, specializing in patients with complex medical and surgical problems of the back of the eye, known as the retina, as well as patients with inflammation in the eye or uveitis. I use the latest diagnostic and therapeutic methods along with a collaborative team effort with colleagues across Duke Eye Center and the Duke Rheumatology and Immunology division to develop the optimum treatment plans for patients with uveitis. Outside of work, I enjoy spending time with the family, traveling, watching sports, and landscape photography. Dr. Grewal is rated as a Distinguished provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Uveitis, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Cataract Removal, and Vitrectomy.

Marco Zarbin is an Ophthalmologist in Newark, New Jersey. Dr. Zarbin is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Endophthalmitis, Retinal Detachment, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Trabeculectomy.

Ashkan Abbey is an Ophthalmologist in Rockwall, Texas. Dr. Abbey has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Cataract Removal.

Carol Shields is an Oncologist and an Ophthalmologist in Philadelphia, Pennsylvania. Dr. Shields is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. Her top areas of expertise are Retinoblastoma, Melanoma of the Eye, Uveal Melanoma, Vitrectomy, and Iridectomy. Dr. Shields is currently accepting new patients.

Ursula Erfurth-Schmidt practices in Vienna, Austria. Ms. Erfurth-Schmidt is rated as an Elite expert by MediFind in the treatment of Late-Onset Retinal Degeneration. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Cataract Removal.

Giuseppe Querques practices in Creteil, France. Mr. Querques is rated as an Elite expert by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Vitrectomy, and Cataract Removal.

Frank Holz practices in Bonn, Germany. Mr. Holz is rated as an Elite expert by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, Vitrectomy, and Trabeculectomy.

Sobha Sivaprasad practices in London, United Kingdom. Sivaprasad is rated as an Elite expert by MediFind in the treatment of Late-Onset Retinal Degeneration. Their top areas of expertise are Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy.

Allen Ho is an Ophthalmologist in Philadelphia, Pennsylvania. Dr. Ho is rated as an Elite provider by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, Vitrectomy, and Cataract Removal. Dr. Ho is currently accepting new patients.

Mark Gillies practices in Sydney, Australia. Mr. Gillies is rated as an Elite expert by MediFind in the treatment of Late-Onset Retinal Degeneration. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), Cataract Removal, and Vitrectomy.

Anat Loewenstein practices in Tel Aviv, Israel. Ms. Loewenstein is rated as an Elite expert by MediFind in the treatment of Late-Onset Retinal Degeneration. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), Vitrectomy, and Cataract Removal.

Hiroko Terasaki practices in Nagoya, Japan. Ms. Terasaki is rated as an Elite expert by MediFind in the treatment of Late-Onset Retinal Degeneration. Her top areas of expertise are Retinopathy Pigmentary Mental Retardation, Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Retinitis Pigmentosa, and Vitrectomy.